Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss
Launched by DARTMOUTH-HITCHCOCK MEDICAL CENTER · Oct 25, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to use a test called the "Visual Evoked Potential" (VEP) to better understand how the brains of individuals with hearing loss respond to visual images. The researchers hope that by measuring a specific brain response, known as the "P300," they can learn more about the connection between hearing loss and brain activity. This information may help improve treatments for people who use hearing aids or cochlear implants.
To participate in this study, you need to be at least 18 years old and have some level of hearing loss. The researchers are looking for people who are current or new patients at the Dartmouth Hitchcock Medical Center's Otolaryngology (ear, nose, and throat) clinic. However, individuals with certain conditions, like severe neurological disorders or blindness, will not be eligible. If you choose to join, you can expect to undergo tests that measure your brain's response to visual cues, and these results will be compared with standard hearing tests to explore how they may predict success with hearing devices.
Gender
ALL
Eligibility criteria
- • Inclusion
- • Subjects will be recruited from the Otolaryngology/Audiology clinic at DHMC with the goal of enrolling subjects with a variety of degrees of hearing loss and central auditory processing dysfunction.
- • Age \> 18 y/o.
- • Current and new patients receiving care in the DHMC Otolaryngology clinic or from the employees of Dartmouth College, DHMC, and the community, will be included as allowed under COVID guidelines.
- • Exclusion
- • Patients with known brain pathology (e.g., CNS tumors, CVA diagnosis, etc...) will be excluded.
- • Patients with severe neurological or neuropsychological disorders will be excluded.
- • Patients with known seizure history will be excluded.
- • Patients with known blindness will be excluded.
- * The following special populations will not be included:
- • Adults unable to consent
- • Individuals who are not yet adults (infants, children, teenagers)
- • Prisoners
About Dartmouth Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center (DHMC) is a leading academic medical institution located in Lebanon, New Hampshire, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a major teaching hospital affiliated with the Geisel School of Medicine at Dartmouth, DHMC integrates cutting-edge clinical trials and translational research into its comprehensive patient care approach. The center emphasizes collaboration across disciplines, aiming to enhance patient outcomes through rigorous scientific investigation, education, and community engagement. With a focus on ethical practices and patient safety, DHMC is dedicated to contributing to the advancement of medical knowledge and improving health care delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lebanon, New Hampshire, United States
Patients applied
Trial Officials
James E Saunders, MD
Principal Investigator
Department of Surgery, Otolaryngology section, Dartmouth Hitchcock Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials